Please login to the form below

Not currently logged in
Email:
Password:

Merck & Co extends med ed portal to India

Pharma company makes Univadis accessible to yet more healthcare professionals
Merck Univadis India

India has become the latest in more than 40 countries to have access to Univadis, a healthcare education and information produced by Merck & Co.

The website, launched in 2001, is free to healthcare professionals and has been developed in conjunction with London-based medical publication The Lancet. It gives users access to exclusive content such as articles, news, research papers, videos and other educational tools.

"We are launching a unique online medical education service to aid comprehensive healthcare management, making available unbiased, reliable scientific medical information," said KG Ananthakrishnan, managing director of Merck's Indian subsidiary MSD Pharmaceuticals Pvt.

“This unique medical education service to support comprehensive healthcare management will provide Indian doctors with updated information to expand their knowledge and expertise”.

It is hoped that Merck's move will help health professions in India, where providing continued medical education for doctors remains challenging.

At present, Indian doctors' medical knowledge is either not updated frequently enough or they find themselves dependent on sponsored conferences for their ongoing education and access to news of industry developments.

“Our partnership with Univadis offers a unique opportunity to increase delivery of the best science to Indian doctors in free and easily accessible format,” added David Collingridge, publishing director for Lancet specialty journals.

Article by
Tara Craig

1st July 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

Mapping content strategies to pharma lifecycle management
In these tough economic times, we should be ramping up our pharma lifecycle management (LCM) strategies. These are well-established strategies for managing and extending the commercial value of products. So...
Back from the future – innovation for pharma
After 5 days of seeing amazing innovations, having discussions about the future of medicine and the practicalities of living on Mars. Plus listening to inspiring speakers from fighter plane-flying physicians...
Cost containment and the German market
The healthcare system’s budget limitations will face further pressure from challenges such as personalised medicine...

Infographics